284 related articles for article (PubMed ID: 25517963)
21. Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas.
Bonnavion R; Teinturier R; Gherardi S; Leteurtre E; Yu R; Cordier-Bussat M; Du R; Pattou F; Vantyghem MC; Bertolino P; Lu J; Zhang CX
J Pathol; 2017 May; 242(1):90-101. PubMed ID: 28188614
[TBL] [Abstract][Full Text] [Related]
22. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
24. High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands.
Seigne C; Auret M; Treilleux I; Bonnavion R; Assade F; Carreira C; Goddard-Léon S; Lavergne E; Chabaud S; Garcia A; Mazoyer S; Lu J; Bachelot T; Frappart L; Zhang CX
J Pathol; 2013 Mar; 229(4):546-58. PubMed ID: 23180448
[TBL] [Abstract][Full Text] [Related]
25. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
[TBL] [Abstract][Full Text] [Related]
26. Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1.
Stålberg P; Grimfjärd P; Santesson M; Zhou Y; Lindberg D; Gobl A; Oberg K; Westin G; Rastad J; Wang S; Skogseid B
J Clin Endocrinol Metab; 2004 May; 89(5):2326-37. PubMed ID: 15126560
[TBL] [Abstract][Full Text] [Related]
27. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?
Ramamoorthy B; Nilubol N
Surg Oncol Clin N Am; 2023 Apr; 32(2):315-325. PubMed ID: 36925188
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
29. Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia.
Harding B; Lemos MC; Reed AA; Walls GV; Jeyabalan J; Bowl MR; Tateossian H; Sullivan N; Hough T; Fraser WD; Ansorge O; Cheeseman MT; Thakker RV
Endocr Relat Cancer; 2009 Dec; 16(4):1313-27. PubMed ID: 19620250
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasia type 1: a chromatin writer's block.
Dreijerink KM; Lips CJ; Timmers HT
J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
[TBL] [Abstract][Full Text] [Related]
31. Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.
Yuan Z; Sánchez Claros C; Suzuki M; Maggi EC; Kaner JD; Kinstlinger N; Gorecka J; Quinn TJ; Geha R; Corn A; Pastoriza J; Jing Q; Adem A; Wu H; Alemu G; Du YC; Zheng D; Greally JM; Libutti SK
Oncotarget; 2016 Mar; 7(11):12633-50. PubMed ID: 26871472
[TBL] [Abstract][Full Text] [Related]
32. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
33. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.
Hamze Z; Vercherat C; Bernigaud-Lacheretz A; Bazzi W; Bonnavion R; Lu J; Calender A; Pouponnot C; Bertolino P; Roche C; Stein R; Scoazec JY; Zhang CX; Cordier-Bussat M
Endocr Relat Cancer; 2013 Dec; 20(6):833-48. PubMed ID: 24157940
[TBL] [Abstract][Full Text] [Related]
34. GFAP-directed Inactivation of Men1 Exploits Glial Cell Plasticity in Favor of Neuroendocrine Reprogramming.
Duan S; Sawyer TW; Sontz RA; Wieland BA; Diaz AF; Merchant JL
Cell Mol Gastroenterol Hepatol; 2022; 14(5):1025-1051. PubMed ID: 35835391
[TBL] [Abstract][Full Text] [Related]
35. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
[TBL] [Abstract][Full Text] [Related]
36. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
Walls GV; Reed AA; Jeyabalan J; Javid M; Hill NR; Harding B; Thakker RV
Endocrinology; 2012 Nov; 153(11):5167-79. PubMed ID: 23024266
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
38. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
39. Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches.
Stevenson M; Lines KE; Thakker RV
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):525-548. PubMed ID: 30098714
[TBL] [Abstract][Full Text] [Related]
40. Functional studies of menin through genetic manipulation of the Men1 homolog in mice.
Balasubramanian D; Scacheri PC
Adv Exp Med Biol; 2009; 668():105-15. PubMed ID: 20175458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]